‘Schedule M’ to be Implemented to Improve Quality of Made-in-India Drugs, Makers to Get One-year Deadline
Companies below Rs 250-crore turnover will get a year for making the transition whereas companies above the turnover of Rs 250 crore will have to execute Schedule M in the next six months starting August 1